Jeffrey Weitz

405 total citations
9 papers, 241 citations indexed

About

Jeffrey Weitz is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Jeffrey Weitz has authored 9 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Internal Medicine, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Hematology. Recurrent topics in Jeffrey Weitz's work include Venous Thromboembolism Diagnosis and Management (8 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Jeffrey Weitz is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (8 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Jeffrey Weitz collaborates with scholars based in Canada, United States and Germany. Jeffrey Weitz's co-authors include Leslie R. Berry, Anthony K.C. Chan, Petr Klement, J.A. Julian, M Andrew, J. Hirsh, Gernot Schabbauer, Lesley Mitchell, Rafał Pawliński and Rolf Dario Frank and has published in prestigious journals such as European Heart Journal, Thrombosis and Haemostasis and Blood Coagulation & Fibrinolysis.

In The Last Decade

Jeffrey Weitz

9 papers receiving 226 citations

Peers

Jeffrey Weitz

CCM

IM

HEMAT

SURGE

PRM

Juan Gaztañaga United States

Mehmet Erdinç Arıkan United States

Amelia Ravera Italy

Ohad S. Bentur United States

A.M. Gabaig France

Harriet E. Allan United Kingdom

Zhenyang Liang China

R. Rajan Canada

Kambiz Parcham-Azad United States

Simone Finocchiaro Italy

Juan Gaztañaga United States

Jeffrey Weitz

217 ×1.5

CCM

81 ×0.6

IM

35 ×0.5

HEMAT

54 ×0.8

SURGE

34 ×2.3

PRM

Citations per year, relative to Jeffrey Weitz Jeffrey Weitz (= 1×) peers Juan Gaztañaga

Countries citing papers authored by Jeffrey Weitz

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Weitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Weitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Weitz more than expected).

Fields of papers citing papers by Jeffrey Weitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Weitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Weitz. The network helps show where Jeffrey Weitz may publish in the future.

Co-authorship network of co-authors of Jeffrey Weitz

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Weitz. A scholar is included among the top collaborators of Jeffrey Weitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Weitz. Jeffrey Weitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Pollack, Charles V., Joanne van Ryn, Paul Reilly, et al.. (2018). P3863Trauma victims requiring dabigatran reversal with idarucizumab in RE-VERSE AD. European Heart Journal. 39(suppl_1). 1 indexed citations

2.

Raskob, Gary E., Walter Ageno, Alexander T. Cohen, et al.. (2017). Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study. Thrombosis and Haemostasis. 117(12). 2406–2414. 7 indexed citations

3.

Hemmrich, Melanie, Eric D. Peterson, Karen Thomitzek, & Jeffrey Weitz. (2016). Spotlight on unmet needs in stroke prevention: The PIONEER AF-PCI, NAVIGATE ESUS and GALILEO trials. Thrombosis and Haemostasis. 116(S 02). S33–S40. 4 indexed citations

4.

Weitz, Jeffrey. (2009). New oral anticoagulants in development. Thrombosis and Haemostasis. 103(1). 62–70. 79 indexed citations

5.

Weitz, Jeffrey. (2006). Emerging anticoagulants for the treatment of venous thromboembolism. Thrombosis and Haemostasis. 96(9). 274–284. 73 indexed citations

6.

Frank, Rolf Dario, Todd Holscher, Gernot Schabbauer, et al.. (2006). A non-anticoagulant synthetic pentasaccharide reduces inflammation in a murine model of kidney ischemia-reperfusion injury. Thrombosis and Haemostasis. 96(12). 802–806. 18 indexed citations

7.

Chan, Anthony K.C., Leslie R. Berry, Petr Klement, et al.. (1998). A novel antithrombin-heparin covalent complex: antithrombotic and bleeding studies in rabbits.. PubMed. 9(7). 587–95. 25 indexed citations

8.

Chan, Anthony K.C., Leslie R. Berry, Petr Klement, et al.. (1998). A novel antithrombin-heparin covalent complex. Blood Coagulation & Fibrinolysis. 9(7). 587–596. 18 indexed citations

9.

Wj, Hodgson, et al.. (1979). General surgical evaluation of a powered device operating at ultrasonic frequencies.. PubMed. 46(2). 99–103. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact